Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.62 |
| ▸ | MMP3 | P08254 | 5/20 | 0.60 |
| ▸ | MMP2 | P08253 | 6/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 9/20 | 0.55 |
| ▸ | HRH2 | P25021 | 7/20 | 0.55 |
| ▸ | HRH1 | P35367 | 7/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9169148 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL4594927 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5097477 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5091513 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5097481 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5090877 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5091525 | 1.00 | HDAC1 (0.62) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL9786700 | 0.98 | MMP3 (0.61) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL5522292 | 0.95 | HRH3 (0.57) | HDAC1HDAC2MMP3MMP2HRH3 | |
| SCHEMBL22120085 | 0.95 | HRH3 (0.57) | HDAC1HDAC2MMP3MMP2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | Rolic Technologies AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-20250066666-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2025-02-27 | — | — | US | disclosed |
| CN-113631686-B | Liquid crystal compound | 罗利克技术有限公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4444822-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| EP-3953434-B1 | LIQUID CRYSTAL COMPOUNDS | ROLIC TECH AG (CH) | 2024-09-04 | — | — | EP | disclosed |
| CN-118318024-A | Liquid crystal compound | 罗利克技术有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2023104545-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| US-7416682-B2 | Photochromic liquid crystals | CHI MEI OPTOELECTRONICS CORPORATION (TW) | 2008-08-26 | — | — | US | disclosed |
| EP-1517977-B1 | PHOTOCHROMIC LIQUID CRYSTALS | QINETIQ LTD (GB) | 2006-10-11 | — | — | EP | disclosed |
| US-20050258396-A1 | Potochromic liquid crystals | QINETIQ LIMITED (GB) | 2005-11-24 | — | — | US | disclosed |
| EP-1517977-A1 | PHOTOCHROMIC LIQUID CRYSTALS | Qinetiq Limited (GB) | 2005-03-30 | — | — | EP | disclosed |
| WO-2005019156-A2 | BIPHENYL-4-CARBOXYLIC ACID ALKYLOXYCARBONYL PHENYL ESTERS AND USES THEREOF | THE UNIVERSITY OF HULL (GB) | 2005-03-03 | — | — | WO | disclosed |
| WO-2004003107-A1 | POTOCHROMIC LIQUID CRYSTALS | QINETIQ LIMITED (GB) | 2004-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | SCO2, LBR, C1R | HDAC1 4042/4885HDAC2 3701/4885MMP3 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.